AIG Hospitals – first to introduce PYtest in India
Released on : Jan. 28, 2026
AIG Hospitals in Hyderabad, one of world’s leading centers for Gastroenterology and Digestive Diseases, became the first hospital in India to introduce PYtest, marking a significant advancement in gastrointestinal diagnostics.
Making the announcement, Dr. D Nageshwar Reddy, Chairman, AIG Hospitals said that AIG had always believed in combining clinical excellence with innovation.
“The introduction of PYtest, marks a significant milestone for gastrointestinal healthcare in India. This test eliminates the fear and hesitation associated with invasive procedures and brings us one step closer to early detection and prevention of serious gastric diseases.”
“Unlike conventional methods such as endoscopy and biopsy-based Rapid Urease Tests, PYtest requires no invasive procedures, no anesthesia and offers results within minutes,” Dr Reddy said.
The test has been clinically validated on Indian patients through a Phase 3 study and demonstrated a sensitivity of 93.8% and specificity of 97.8%, with no serious adverse events reported, confirming the accuracy of PYtest in the Indian population.
“Helicobacter pylori is one of the most common bacterial infections in India, linked to chronic gastritis, peptic ulcer disease, gastric cancer and MALT lymphoma. By way of a simple breath-based test, PYtest better enables the early diagnosis and treatment of H. pylori, potentially reducing complications and improving long-term outcomes.
“The introduction of PYtest in India is part of a strategic collaboration to further research on H. pylori in the Indian population. To advance this mission, AIG Hospitals has also established the Prof. Barry Marshall H. pylori Research Centre, dedicated to studying bacterial pathogenesis, antibiotic resistance patterns and innovative diagnostic tools tailored for Indian patients,” said Dr Reddy.